Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients

Figure 7

The chemotherapy sensitivity of bosutinib (a), bryostatin.1 (b), dasatinib (c), imatinib (d), methotrexate (e), midostaurin (f), pazopanib (g), bexarotene (h), and bicalutamide (i).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)